Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020

Pancreatic cancer is one of the more dismal gastrointestinal tumors due to the obscure symptoms in the early stage of disease, rapid progression and insensitivity to chemotherapy. The 5-year survival rate is only approximately 9% for patients with pancreatic cancer. In the recent years, with the cha...

Full description

Bibliographic Details
Main Author: TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun
Format: Article
Language:English
Published: Editorial Office of China Oncology 2021-01-01
Series:Zhongguo aizheng zazhi
Subjects:
Online Access:http://www.china-oncology.com/fileup/1007-3639/PDF/20210101.pdf
_version_ 1817977766683869184
author TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun
author_facet TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun
author_sort TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun
collection DOAJ
description Pancreatic cancer is one of the more dismal gastrointestinal tumors due to the obscure symptoms in the early stage of disease, rapid progression and insensitivity to chemotherapy. The 5-year survival rate is only approximately 9% for patients with pancreatic cancer. In the recent years, with the change in dietary structure and life style as well as the improvement of clinical detection rate, the incidence of pancreatic cancer is increasing annually, and it severely undermines the health of people. However, the advance in molecular biology provides more potential targets for the treatment of pancreatic cancer. Besides, well-conducted clinical trials continue to translate more theoretical innovations from bench to bedside. These both can improve the prognosis of pancreatic cancer eventually. The present review summarized the important findings in pancreatic cancer research in 2020.
first_indexed 2024-04-13T22:20:47Z
format Article
id doaj.art-1ecd30b75e7545a789b0e2f2a1cd683e
institution Directory Open Access Journal
issn 1007-3639
language English
last_indexed 2024-04-13T22:20:47Z
publishDate 2021-01-01
publisher Editorial Office of China Oncology
record_format Article
series Zhongguo aizheng zazhi
spelling doaj.art-1ecd30b75e7545a789b0e2f2a1cd683e2022-12-22T02:27:14ZengEditorial Office of China OncologyZhongguo aizheng zazhi1007-36392021-01-0131111010.19401/j.cnki.1007-3639.2021.01.001Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun0Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Pancreatic Cancer Institute, Fudan University; Shanghai Pancreatic Cancer Institute, Shanghai 200032, ChinaPancreatic cancer is one of the more dismal gastrointestinal tumors due to the obscure symptoms in the early stage of disease, rapid progression and insensitivity to chemotherapy. The 5-year survival rate is only approximately 9% for patients with pancreatic cancer. In the recent years, with the change in dietary structure and life style as well as the improvement of clinical detection rate, the incidence of pancreatic cancer is increasing annually, and it severely undermines the health of people. However, the advance in molecular biology provides more potential targets for the treatment of pancreatic cancer. Besides, well-conducted clinical trials continue to translate more theoretical innovations from bench to bedside. These both can improve the prognosis of pancreatic cancer eventually. The present review summarized the important findings in pancreatic cancer research in 2020.http://www.china-oncology.com/fileup/1007-3639/PDF/20210101.pdfpancreatic cancer| basic research|clinical research
spellingShingle TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
Zhongguo aizheng zazhi
pancreatic cancer| basic research|clinical research
title Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
title_full Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
title_fullStr Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
title_full_unstemmed Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
title_short Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
title_sort advances in basic research clinical diagnosis and treatment of pancreatic cancer in 2020
topic pancreatic cancer| basic research|clinical research
url http://www.china-oncology.com/fileup/1007-3639/PDF/20210101.pdf
work_keys_str_mv AT tangrongshisizhangboxujinwangweiyuxianjun advancesinbasicresearchclinicaldiagnosisandtreatmentofpancreaticcancerin2020